Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas (Q30425423)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas (English)

1 reference

Europe PubMed Central

12 August 2017

Soldano Ferrone

5

object named as

Soldano Ferrone

1 reference

Europe PubMed Central

12 August 2017

author name string

Helen P Cathro

1

1 reference

Europe PubMed Central

12 August 2017

Mark E Smolkin

2

1 reference

Europe PubMed Central

12 August 2017

Dan Theodorescu

3

1 reference

Europe PubMed Central

12 August 2017

Vickie Y Jo

4

1 reference

Europe PubMed Central

12 August 2017

Henry F Frierson

6

1 reference

Europe PubMed Central

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 September 2009

1 reference

Europe PubMed Central

12 August 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

12 August 2017

59

1 reference

Europe PubMed Central

12 August 2017

3

1 reference

Europe PubMed Central

12 August 2017

465-472

1 reference

Europe PubMed Central

12 August 2017

https://scigraph.springernature.com/pub.10.1007/s00262-009-0765-9

0 references

Production and characterization of monoclonal antibodies against major histocompatibility complex class I chain-related gene A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

The immunotherapy of prostate and bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Current and new strategies in immunotherapy for superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Antigen-processing machinery breakdown and tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

20 June 2018

A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3426234

26 November 2018

Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-DR epitope region definition by use of monoclonal antibody probes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19756593

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00262-009-0765-9

1 reference

Europe PubMed Central

12 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30425423&oldid=1638817172"